Companies
(73)
AAC Clyde Space
ALM Equity
Alzinova
Arion Bank
Arlandastad Group
Ascelia Pharma
Bactiguard
Bergman & Beving
Besqab
BioPorto
Björn Borg
Bokusgruppen
Bonava
BTS Group
Byggmästaren
CAG Group
Calviks
Carasent
CDON
Clavister
Clemondo Group
eEducation Albert
Elanders
Elicera Therapeutics
Eolus
Ependion
EQL Pharma
Faron Pharmaceuticals
FluoGuide
Gentoo Media
GiG Software
HAKI Safety
HANZA
Iconovo
Idun Industrier
InfraCom
Initiator Pharma
Intervacc
ITAB Group
Kebni
Lifecare ASA
Lindex Group
Logistri
Lumi Education Group
Lytix Biopharma
Medivir
Mentice
Micro Systemation
MilDef Group
Net Insight
Nordic LEVEL Group
Orexo
Ortoma
OssDsign
Paxman
Pierce
PowerCell
Pricer
Qualisys
Relais Group
SaltX
Scanfil
Sensys Gatso Group
Sleep Cycle
Solar Foods
Spago Nanomedical
Svedbergs Group
Taaleri
Terranor
Vertiseit
Vivesto
W5 Solutions
Waystream
Sweden
Real Estate
Near term
6-12 MONTHS
Bonava’s earnings recovery continues, but the German slowdown has delayed its pace. Weaker investor demand and postponed starts reduce revenue growth and operating leverage, prompting lower guidance and earnings estimates. Sweden’s recovery and resilient Baltic demand provide support, while German cost savings should gradually strengthen profitability during 2027. Q4 handovers should release cash and reduce debt, but higher production and land commitments will continue to absorb capital. Execution and cash conversion remain the key near-term proof points..
Long term
6+ YEARS
Bonava offers exposure to a volume-led recovery in structurally undersupplied housing markets. Germany remains the core earnings engine, complemented by Sweden’s recovery potential and the Baltics’ profitable growth. A leaner organisation and disciplined project selection should support margin expansion as activity normalises. However, sustained shareholder value creation requires the earnings recovery to translate into stronger cash flow, lower leverage and higher returns on equity. Capital efficiency is therefore as important as production growth.
German demand and concentration: Higher interest rates and uncertainty can delay consumer purchases and investor transactions in Bonava’s largest earnings market.
Execution and margins: Delayed starts, pricing pressure or weaker cost absorption could prolong the recovery and offset expected restructuring savings.
Cash flow and funding: Handover delays, rising production and land payments could keep capital tied up and debt elevated, limiting financial flexibility.
Price
Fair range high value
Fair range low value
The upper end of our valuation is derived from our scenario analysis with a starting point of 3,750 housing starts per year, an EBIT margin of 9.0% and EPS of SEK1.8. We apply a normalised P/E of 12.0x to our EPS forecast. The lower end of our valuation is derived from our scenario analysis with a starting point of 3,250 housing starts per year, an EBIT margin of 8.0% and EPS of SEK1.2. We apply the same normalised P/E of 12.0x to our EPS forecast multiples.
Our fair value range for Bonava is derived from a scenario-based valuation framework designed to capture the cyclical nature of residential development. By applying explicit assumptions for normalised production volumes, EBIT margins and valuation multiples, we anchor the analysis in mid-cycle earnings capacity rather than short-term volatility. The valuation methodology is aligned with the framework applied to JM, using its long-term average P/E multiple as a reference point, thereby ensuring a transparent, consistent and investor-relevant comparison.
About DNB Carnegie Access
DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.
Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.
Private Banking
Tailored wealth management. Your financial future, personalized.
Montrose
A digital investment platform designed for passionate investors.
DNB Carnegie
Leading Nordic investment bank and wealth management.
© Copyright DNB Carnegie Investment Bank AB